GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancerKenneth L. Scott, Lynda Chin, Valsamo Anagnostou et al.|Nature|2009Cited by 353
Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab TherapyPaolo A. Ascierto, Victoria Atkinson, Georgina V. Long et al.|JAMA Oncology|2018Cited by 345